Lewis KD - Search Results

1

A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF.

Lewis KD, Gibbs P, O'Day S, Richards J, Weber J, Anderson C, Zeng C, Baron A, Russ P, Gonzalez R. Lewis KD, et al. Cancer Invest. 2005;23(4):303-8. doi: 10.1081/cnv-58832. Cancer Invest. 2005. PMID: 16100942 Clinical Trial.

2

A young woman with melanoma diagnosed during pregnancy.

Lewis KD, Gonzalez R, Robinson WA, Fitzpatrick JE, McCarter MD, Braden C. Lewis KD, et al. Oncology (Williston Park). 2004 Jun;18(7):794-9. Oncology (Williston Park). 2004. PMID: 15255167 No abstract available.

3

Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.

Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Wang HJ, Elashoff RM, Takeuchi H, Umetani N, Hoon DS. Koyanagi K, et al. J Clin Oncol. 2005 Nov 1;23(31):8057-64. doi: 10.1200/JCO.2005.02.0958. J Clin Oncol. 2005. PMID: 16258104 Free PMC article.

4

A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma.

Lewis KD, Thompson JA, Weber JS, Robinson WA, O'Day S, Lutzky J, Legha SS, Floret S, Ruvuna F, Gonzalez R. Lewis KD, et al. Invest New Drugs. 2006 Jan;24(1):89-94. doi: 10.1007/s10637-005-4544-y. Invest New Drugs. 2006. PMID: 16379038 Clinical Trial.

5

Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.

Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Kuo C, Wang HJ, Milford R, Morton DL, Hoon DS. Koyanagi K, et al. Clin Cancer Res. 2006 Feb 15;12(4):1137-43. doi: 10.1158/1078-0432.CCR-05-1847. Clin Cancer Res. 2006. PMID: 16489066 Free PMC article.

6

Lymphangiomatosis masquerading as metastatic melanoma.

Qutub W, Lewis K, Gonzalez R, Quaife R, Russ P, McCarter M. Qutub W, et al. Am Surg. 2006 Apr;72(4):367-70. Am Surg. 2006. PMID: 16676867 Review.

7

Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.

Lewis KD, Robinson WA, McCarter M, Pearlman N, O'Day SJ, Anderson C, Amatruda TT, Baron A, Zeng C, Becker M, Dollarhide S, Matijevich K, Gonzalez R. Lewis KD, et al. J Clin Oncol. 2006 Jul 1;24(19):3157-63. doi: 10.1200/JCO.2005.04.5344. J Clin Oncol. 2006. PMID: 16809738 Clinical Trial.

8

Metastatic malignant melanoma from an unknown primary presenting as a large axillary mass.

Lewis KD, Dollarhide S, Fitzpatrick JE, Gonzalez R, High WA, McCarter MD, Olsen C, Raben D. Lewis KD, et al. Oncology (Williston Park). 2006 Jun;20(7):763-70. Oncology (Williston Park). 2006. PMID: 16841798 Free article. No abstract available.

9

Metastatic melanoma in the breast: a report of 27 cases.

Ravdel L, Robinson WA, Lewis K, Gonzalez R. Ravdel L, et al. J Surg Oncol. 2006 Aug 1;94(2):101-4. doi: 10.1002/jso.20592. J Surg Oncol. 2006. PMID: 16847918

10

Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.

Pearlman NW, McCarter MD, Frank M, Hurtubis C, Merkow RP, Franklin WA, Gonzalez R, Lewis K, Roaten JB, Robinson WA. Pearlman NW, et al. Am J Surg. 2006 Dec;192(6):878-81. doi: 10.1016/j.amjsurg.2006.08.062. Am J Surg. 2006. PMID: 17161112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters